Article
Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer.
Breast cancer research : BCR - 1 Jan 2006
Birgisdottir Valgerdur, Stefansson Olafur A, Bodvarsdottir Sigridur K, Hilmarsdottir Holmfridur, Jonasson Jon G, Eyfjord Jorunn E
Abstract excerpt
INTRODUCTION: BRCA1 or BRCA2 germline mutations increase the risk of developing breast cancer. Tumour cells from germline mutation carriers have frequently lost the wild-type allele. This is predicted to result in genomic instability where cell survival depends upon dysfunctional checkpoint mechanisms. Tumorigenic potential could then be acquired through further genomic alterations. Surprisingly, somatic BRCA...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
